Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Aug 15, 2021; 13(8): 959-969
Published online Aug 15, 2021. doi: 10.4251/wjgo.v13.i8.959
Published online Aug 15, 2021. doi: 10.4251/wjgo.v13.i8.959
Investigation of the factors influencing surgical treatment of duodenal gastrointestinal stromal tumors
Yun-Zi Wu, Yang Li, Xiao-Hao Zheng, Yan-Tao Tian, Yi-Bin Xie, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Ming Wu, Department of Gastric Surgery, Yun Cheng Center Hospital, Yucheng 043300, Shanxi Province, China
Author contributions: Wu YZ, Xie YB and Li Yang designed the study; Wu YZ and Wu Ming performed the research; Wu YZ and Zheng YH analyzed the data; Wu YZ and Li Yang wrote the paper; Xie YB and Tian YT revised the manuscript for final submission.
Supported by CAMS Initiative for Innovative Medicine , No. 2016-I2M-1-007 .
Institutional review board statement: The study was reviewed and approved by the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Informed consent statement: All study participants or their legal guardian provided written informed consent prior to study enrollment.
Conflict-of-interest statement: We declare that we have no financial or personal relationships with other individuals or organizations that inappropriately influenced our work and that there is no professional or other personal interest of any nature in any product, service and/or company that could be construed as influencing the position presented in or the review of the manuscript.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yi-Bin Xie, MD, Chief Doctor, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan South Lane, Chaoyang District, Beijing 100021, China. yibinxie_2003@163.com
Received: June 9, 2021
Peer-review started: June 9, 2021
First decision: June 15, 2021
Revised: June 18, 2021
Accepted: July 5, 2021
Article in press: July 5, 2021
Published online: August 15, 2021
Processing time: 66 Days and 9.6 Hours
Peer-review started: June 9, 2021
First decision: June 15, 2021
Revised: June 18, 2021
Accepted: July 5, 2021
Article in press: July 5, 2021
Published online: August 15, 2021
Processing time: 66 Days and 9.6 Hours
Core Tip
Core Tip: We investigated the factors influencing the surgical treatment of duodenal gastrointestinal stromal tumors, and found that if the primary tumor was in the descending part of the duodenum, tumor size was ≥ 5.0 cm and tumor risk grade was medium or high, Whipple surgery was performed.